The founders of Aware of Eyeem are earning 14 million

Six months ago, the maker of Eyeem announced the name of its new project: Aware. Lakestar is now investing in the new technology company.

Florian Meissner (left) and Ramzi Rizk (middle) have already founded Eyeem. Now they are building Aware with Ferdinand Schmidt-Thomé (right).
Aware of

Florian Meissner and his team have been working on the project for a year: With Aware, users should be able to control their blood counts and call the results in understandable language through the app. The first tests have already started, but the entry into the market is not planned until the end of the year. So the health app may not show much yet, but investors are now investing the equivalent of € 14 million in the company. When it was founded, Aware received a seven-figure sum from Cherry Ventures, the June Fund from Google CEO Philipp Schindler and Teleclinic co-founder Katharina Jiinger. The current seed round was led by Lakestar, with the participation of previous shareholders as well as the founders of Unicorn, such as Omio boss Naren Shaam and Christian Reber, Pitch founder.

Florian Meissner and co-founder Ramzi Rizk have previously created the Eyeem photo portal and sold it to a Swiss company last summer for € 34 million. Your third ally in Aware is banker Ferdinand Schmidt-Thomé, who, however, does not act as a managing director.

You have workshops in the style of Apple stores

“We know how fit we are and how healthy we sleep, but we do not know the values ​​of our blood,” Meissner said of his idea in an interview with the start-up scene. Aware wants to set up its own logistics lab, with locations in several major cities – starting in Berlin. There, qualified personnel should take the client’s blood and analyze it within 24 hours, for example for cholesterol, iron content or glucose levels. Customers book an appointment through an app. According to Meissner, the labs should be “a mix of an Apple store and a test center.”

Meissner deliberately relies on venous blood sampling and no test kits for home use, as convicted founder Elisabeth Holmes and Theranos have tried. In his opinion, fast speed kits, which require only a few drops of blood from the finger, would still leave unanswered questions. And patients should clarify the results after a visit to a doctor and another blood test anyway.

also read

Elizabeth Holmes takes a long shot, but it is off-target
She was hailed as the new Steve Jobs, now threatened with imprisonment: the rise and fall of once-younger self-made billionaire Elizabeth Holmes

Meissner cannot yet say whether legitimate health insurance companies will pay for Aware or whether the exams are private services. Aware has held health days with some companies in recent weeks, where blood samples were taken from employees. Thus, the startup acquired its first test customers. The technology company wants to continue the events in the future.

The idea is that customers will recognize early when they are sick. According to Meissner, Aware users will need to test twice a year to stay informed. If necessary, also through a subscription model every three or six months. “We firmly believe that we can fight chronic diseases in this way.” In the next step, the startup creates a platform on which users can share their data and, in case of illness, exchange information with the affected Global. Or compare their values ​​with those of well-known athletes or family members.

Leave a Comment